Search Results
May 26, 2026, 08:18 ET CGTN: Společná budoucnost: Čína a Srbsko posouvají komplexní strategické partnerství na novou úroveň
nástupem platnosti dohody o volném obchodu mezi Čínou a Srbskem dne 1. července 2024 se na čínský trh dostává stále více srbských specialit, jako je víno, med, hovězí a skopové maso. Zároveň byly dokončeny projekty realizované za účasti čínských společností, například obchvat Bělehradu a obchvat města Gornji
More news about: CGTN
May 26, 2026, 07:30 ET Hydreight Technologies Announces Timing of Q1 2026 Financial Results and Investor Webcast
directly to patients at home, office or hotel. Hydreight is bridging the gap between provider compliance and patient convenience, empowering nurses, med spa technicians, and other licensed healthcare professionals. The Hydreight platform allows healthcare professionals to deliver services independently,
More news about: Hydreight Technologies Inc.
May 26, 2026, 07:25 ET Tata Elxsi Launches ViTel™, a Material Intelligence Solution for Med-Tech Powered by Viridium AI
Med-Tech engineering and regulatory expertise, knowledge that has been embedded into how the solution reasons about material risk, compliance, and sourcing
More news about: Tata Elxsi
May 25, 2026, 22:53 ET Hansa Biopharma Announces Late-Breaking Abstract from ConfIdeS Phase 3 Trial Selected for Oral Presentation at ATC 2026
https://www.ema.europa.eu/en/documents/product-information/idefirix-epar-product-information_en.pdf.Jordan SC, et al. IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation. N Engl J Med 2017;377:442-453. DOI: 10.1056/NEJMoa161251Winstedt L, et al. Complete Removal of Extracellular IgG Antibodies in a Randomized Dose-Escalation
More news about: Hansa Biopharma AB
May 25, 2026, 22:52 ET Hansa Biopharma Announces Late-Breaking Abstract from ConfIdeS Phase 3 Trial Selected for Oral Presentation at ATC 2026
https://www.ema.europa.eu/en/documents/product-information/idefirix-epar-product-information_en.pdf.Jordan SC, et al. IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation. N Engl J Med 2017;377:442-453. DOI: 10.1056/NEJMoa161251Winstedt L, et al. Complete Removal of Extracellular IgG Antibodies in a Randomized Dose-Escalation
More news about: Hansa Biopharma AB
May 25, 2026, 08:45 ET A single dose of Lilly's PCSK9 base editor, VERVE-102, reduced PCSK9 by up to 88% and LDL-C by up to 62%, with durable effects supporting its potential as a one-time treatment for hypercholesterolemia
K., et al. Prevalence of Familial Hypercholesterolemia and Its Association with Cardiovascular Risk in a Cross-Sectional Adult Population. J Clin Med. 2025 Nov 19;14(22):8213. doi: 10.3390/jcm14228213.3. Stark, B., et al. Global Prevalence of Coronary Artery Disease: An Update from the Global
More news about: Eli Lilly and Company
May 25, 2026, 03:05 ET Göteborgs Stad välkomnar MAGNA-TILES® och häver avstängning efter bekräftande säkerhetstester
skolor kan lita på – inte bara i Sverige, utan i alla länder runt om i världen. Vi är glada över att barnen i Göteborg återigen kan uppleva glädjen med att leka med MAGNA-TILES."MAGNA-TILES har åtnjutit förtroende från familjer, pedagoger och skolor i nästan 30 år. Detta långvarigt upparbetade förtroende
More news about: MAGNA-TILES®
May 25, 2026, 03:05 ET Göteborgs kommune byder MAGNA-TILES® velkommen og ophæver forbuddet efter bekræftende sikkerhedstest
BOLINGBROOK, Ill., 25. maj 2026 /PRNewswire/ -- MAGNA-TILES kan med glæde meddele, at Göteborgs kommune har omstødt sin tidligere beslutning vedrørende MAGNA-TILES-produkter, efter at endelige testresultater har bekræftet,
More news about: MAGNA-TILES®
May 22, 2026, 06:36 ET Byen Göteborg hilser MAGNA-TILES® velkomment, reverserer suspensjon etter bekreftelsessikkerhetstesting
Dette følger MAGNA-TILES' uttalelse av 29. april 2026 om produktprøving og diskusjoner med lokale myndigheter i Sverige. Göteborg by har informert MAGNA-TILES om at den vil kommunisere denne viktige oppdateringen til sine kunder og gjennom
More news about: MAGNA-TILES®
May 21, 2026, 21:52 ET 아스트라제네카, 로슈진단 아시아태평양과 함께 유방암 및 폐암 첨단 병리학의 지속 가능한 생태계 가속화 지원
9. Fountzilas E, et al. Genome Med. 2022 Aug 31;14(1):101.
More news about: AstraZeneca
May 21, 2026, 17:00 ET Sapience Therapeutics Provides Positive Data Update from Phase 2 Trial of Lucicebtide Plus SOC in Patients with Glioblastoma at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
38994023; PMCID: PMC11234274.4 Stupp, R., et al., Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med, 2005. DOI: 10.1056/NEJMoa043330.PMID: 157580095 Stupp R, Taillibert S, Kanner A, et al. Effect of Tumor-Treating Fields Plus Maintenance
More news about: Sapience Therapeutics, Inc.
May 21, 2026, 17:00 ET Boehringer Ingelheim's oncology portfolio shows strong promise across multiple cancers at ASCO 2026
Szczęsna A, Havel L, Krzakowski M, Hochmair MJ, et al. First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer. N Engl J Med. 2018;379(23):2220–2229. doi:10.1056/NEJMoa1809064 13 ClinicalTrials.gov. DAREON-9 (NCT05990738). Accessed May 2026.14
More news about: Boehringer Ingelheim
May 21, 2026, 08:23 ET Scientific Longevity Company Immorta Bio Appoints Former Ernst & Young Health Sciences Partner Howard Brooks to Corporate Board of Directors
[email protected] 1 Ichim et al. Reduction of solid tumors by senescent cell immunization. J Transl Med. 2025 Nov 28;23(1):1365.
More news about: Immorta Bio Inc.
May 21, 2026, 06:00 ET Spring Contract Signings Hit a Four-Year High As Sellers Get Real on Price, New Realtor.com® Report
Total vs. 2025Med. PPSF, Apr '26 YoY GrowthPrice
More news about: Realtor.com
May 21, 2026, 02:00 ET Yozma riktar in sig på Europa med en prisvärd elektrisk offroadlösning med IN 10
beredskap för europeiska förare. I takt med att elektrisk mobilitet blir en allt större prioritet i regionen erbjuder Yozma IN 10 ett renare alternativ med lägre underhåll än traditionella bensindrivna dirtbikes.Yozma IN 10 finns nu tillgänglig i hela Europa, med den starkaste tidiga efterfrågan i
More news about: Yozmasports
May 20, 2026, 18:00 ET Mercy Medical Center Medical-Surgical Nursing Team Earns Prestigious AMSN PRISM Award®
overseeing a broad range of patient care responsibilities.The PRISM Award®, which stands for "Premier Recognition In the Specialty of Med-Surg," is the first award of its kind recognizing medical-surgical nursing units in the United States and internationally. Co-sponsored by AMSN and the
More news about: Mercy Medical Center
May 20, 2026, 02:21 ET Focus Physicians Group PLLC Launches as Texas's Premier Board-Certified Physician Group, Serving Eight Markets Statewide and Actively Recruiting Top Physicians
replacing locum tenens instability with a consistent, quality-assured group practice model.Building a wellness oversight network that ensures Texas med spas and health clinics operate with real physician involvement — protecting patients and operators alike.CALLING ALL PHYSICIANS — JOIN
More news about: Focus Health
May 20, 2026, 01:54 ET AstraZeneca dan Roche Diagnostics Asia Pacific Pacific Perkuat Pengembangan Patologi Digital Berbasis AI untuk Kanker Payudara dan Paru
9. Fountzilas E, et al. Genome Med. 2022 Aug 31;14(1):101.
More news about: AstraZeneca
May 20, 2026, 01:51 ET स्तन तथा फेफड़ों के कैंसर में एडवांस पैथोलॉजी के लिए एक स्थायी इकोसिस्टम को गति देने में सहायता करने के लिए AstraZeneca ने Roche Diagnostics Asia Pacific के साथ सहयोग किया
9. Fountzilas E, इत्यादि Genome Med. 31 अगस्त 31; 2022 , 14(1):101.फ़ोटो -
More news about: AstraZeneca
May 19, 2026, 16:51 ET Beverly Hills MD ProRetinol Age Rewind x3 Officially Launches: A New Era of Gentle, Slow-Released Retinol Skincare Backed by Plastic Surgeons
Mexico to hold a Regenerative Medicine License. Continuing their commitment to innovation and beauty, Dr. Layke and Dr. Danielpour debuted their first med spa,
More news about: Beverly Hills MD
May 19, 2026, 10:00 ET Two Pharma Companies Now Own Nearly 100% of GLP-1 Citations Inside ChatGPT, Claude and Perplexity, New 5W Index Finds
WeightWatchers have pivoted into the GLP-1 era with very different financial outcomes but similar citation outcomes. Noom's 2022 launch of Noom Med positioned the company as "behavioral change plus medication access," and AI now cites it as the category's hybrid default. WeightWatchers filed Chapter
More news about: 5W Public Relations
May 19, 2026, 09:00 ET Metabolic Supply Group (MSG) Announces Strategic Partnership with Orbit Health to Power Nationwide Growth and Patient Access
(MSG)Metabolic Supply Group (MSG) operates as a provider network and sourcing administrator, supporting healthcare practices, telehealth platforms, med spas, wellness clinics, and longevity providers nationwide. MSG specializes in pharmacy network coordination, operational support, sourcing infrastructure,
More news about: Metabolic Supply Group
May 19, 2026, 06:50 ET Bliss Launches Bliss Pro™, an Accessible Pro-Grade Skincare Line of Next-Gen Ingredients and Treatments
the full spectrum of skin concerns."Our Bliss consumers' perception of spa and treatment has expanded and shifted over the past few years to med spa culture and looking globally for what can really make a difference in their skin," said Emily Woods, GM of Bliss. "We are applying our same development
More news about: Bliss
May 19, 2026, 06:00 ET A Shifting Housing Market Drives Down Payments to Four-Year Low
Purchase PriceMed. Down Payment ($ amt)2019
More news about: Realtor.com
May 19, 2026, 02:26 ET RefluxStop® gains momentum at DDW 2026
procedure's unique mechanism of action and excellent clinical outcomes at Digestive Disease Week (DDW) 2026 in Chicago. Independent surgeon, Dr. med. Yves Borbély of the Department of Visceral Surgery and Medicine, Inselspital Bern, Switzerland, a pioneer RefluxStop® surgeon, reported his excellent
More news about: Implantica